ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss
Clinical trial NCT04065269 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04065269
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-27
- Primary completion
- 2026-08-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.